Ardent Health (ARDT) Stock Price, News & Analysis

Company Overview

Ardent Health is a healthcare provider that operates hospitals, outpatient facilities and physician practices in the United States. The company delivers a broad range of services, including emergency and inpatient care, surgery, primary care, specialty care, diagnostic services and other outpatient treatments.

Ardent serves communities through regional health systems and affiliated medical groups, with operations primarily in Texas, Oklahoma, New Mexico and Kansas. Its facilities include acute-care hospitals as well as ambulatory and other sites designed to provide care closer to patients’ homes.

The company traces its roots to Ardent Health Services, a healthcare operator established in 1993. Ardent Health became a publicly traded company on the New York Stock Exchange in 2024. Martin Bonick serves as president and chief executive officer.

Key Stats

• Today's Range: $10.91 to $11.44
• 50-Day Range: $10.24 to $11.60
• 52-Week Range: $7.71 to $15.48
• Volume: 568,329 shs
• Average Volume: 435,487 shs
• Market Capitalization: $1.60 billion
• P/E Ratio: 20.62
• Dividend Yield: N/A
• Price Target: $12.79
• Consensus Rating: Hold

Ardent Health Stock Analysis - MarketRank™

Ardent Health scored higher than 65% of companies evaluated by MarketBeat, and ranked 271st out of 883 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

Ardent Health has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 7 buy ratings, 6 hold ratings, and 2 sell ratings.

Upside Potential

Ardent Health has a consensus price target of $12.79, representing about 12.8% upside from its current price of $11.34.

Amount of Analyst Coverage

Ardent Health has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.8 / 5
• Proj. Earnings Growth: 25.00%

Earnings Growth

Earnings for Ardent Health are expected to grow by 25.00% in the coming year, from $0.96 to $1.20 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Ardent Health is 20.62, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.00.

Price to Earnings Ratio vs. Sector

The P/E ratio of Ardent Health is 20.62, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.15.

Price to Earnings Growth Ratio

Ardent Health has a PEG Ratio of 3.13. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Ardent Health has a P/B Ratio of 0.96. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.35% of the float of Ardent Health has been sold short.

Short Interest Ratio / Days to Cover

Ardent Health has a short interest ratio ("days to cover") of 10.71, which indicates bearish sentiment.

Change versus previous month

Short interest in Ardent Health has recently increased by 1.22%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Ardent Health does not currently pay a dividend.

Dividend Growth

Ardent Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.49

News Sentiment

Ardent Health has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Ardent Health this week, compared to 8 articles on an average week.

Search Interest

4 people have searched for ARDT on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Ardent Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Ardent Health insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.90% of the stock of Ardent Health is held by insiders.

Percentage Held by Institutions

Ardent Health has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 10/10/2026
• Next Earnings (Estimated): 11/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NYSE:ARDT
• Previous Symbol: NYSE:ARDT
• CIK: 1756655
• Web: ardenthealth.com
• Phone: (615) 296-3000
• Fax: N/A
• Employees: 25,200
• Year Founded: 2001

Price Target and Rating

• Average Price Target for Ardent Health: $12.79
• High Price Target: $17.00
• Low Price Target: $10.00
• Potential Upside/Downside: +12.8%
• Consensus Rating: Hold
• Rating Score (0-4): 2.33
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.55
• Trailing P/E Ratio: 20.62
• Forward P/E Ratio: 11.81
• P/E Growth: 3.13
• Net Income: $135.81 million
• Net Margins: 1.22%
• Pretax Margin: 3.25%
• Return on Equity: 10.35%
• Return on Assets: 3.36%

Debt

• Debt-to-Equity Ratio: 0.61
• Current Ratio: 2.10
• Quick Ratio: 1.99

Sales & Book Value

• Annual Sales: $6.32 billion
• Price / Sales: 0.25
• Cash Flow: $2.81 per share
• Price / Cash Flow: 4.03
• Book Value: $11.78 per share
• Price / Book: 0.96

Miscellaneous

• Outstanding Shares: 141,050,000
• Free Float: 138,366,000
• Market Cap: $1.60 billion
• Optionable: Optionable
• Beta: 0.72